Алваноцит

Алваноцит (Valganciclovir Hydrochloride) is an antiviral medication used to treat cytomegalovirus (CMV) infections. This oral medication helps manage CMV retinitis and prevent CMV disease in transplant patients. It belongs to the class of antiviral drugs and is available in tablet form.

Valganciclovir Hydrochloride is primarily used to treat cytomegalovirus (CMV) infections, including CMV retinitis in patients with AIDS. It is also prescribed to prevent CMV disease in patients who have received organ transplants. The medication works by slowing the growth of the virus, helping to control the infection. It is not a cure but can manage symptoms and reduce complications.

Common effects of Valganciclovir Hydrochloride may include nausea, diarrhea, and headache. Some patients may experience fatigue or dizziness. These effects are typically mild and temporary. If symptoms persist or worsen, it is advisable to consult a healthcare provider.

Valganciclovir Hydrochloride should be handled with care, especially by individuals who are pregnant or breastfeeding. It is important to avoid contact with broken tablets, as the medication can be harmful if ingested accidentally. Keep the medication out of reach of children and pets. Regular blood tests may be required to monitor for potential side effects.

Valganciclovir Hydrochloride may interact with other medications, including certain antivirals, immunosuppressants, and drugs that affect blood cell counts. Alcohol and other substances that affect the kidneys should be used cautiously. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.